Crawford J - Search Results

1

Overcoming obstacles in the design of cancer anorexia/weight loss trials.

Le-Rademacher JG, Crawford J, Evans WJ, Jatoi A. Le-Rademacher JG, et al. Among authors: crawford j. Crit Rev Oncol Hematol. 2017 Sep;117:30-37. doi: 10.1016/j.critrevonc.2017.06.008. Epub 2017 Jun 24. Crit Rev Oncol Hematol. 2017. PMID: 28807233 Free PMC article. Review.

2

A review of relative dose intensity and survival in patients with metastatic solid tumors.

Havrilesky LJ, Reiner M, Morrow PK, Watson H, Crawford J. Havrilesky LJ, et al. Among authors: crawford j. Crit Rev Oncol Hematol. 2015 Mar;93(3):203-10. doi: 10.1016/j.critrevonc.2014.10.006. Epub 2014 Oct 12. Crit Rev Oncol Hematol. 2015. PMID: 25459671 Review.

3

Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials).

Crawford J, Prado CM, Johnston MA, Gralla RJ, Taylor RP, Hancock ML, Dalton JT. Crawford J, et al. Curr Oncol Rep. 2016 Jun;18(6):37. doi: 10.1007/s11912-016-0522-0. Curr Oncol Rep. 2016. PMID: 27138015 Free PMC article. Review.

4

A quick scoping review of efficacy, safety, economic, and health-related quality-of-life outcomes of short- and long-acting erythropoiesis-stimulating agents in the treatment of chemotherapy-induced anemia and chronic kidney disease anemia.

Arantes LH Jr, Crawford J, Gascon P, Latymer M, Launay-Vacher V, Rolland C, Scotte F, Wish J. Arantes LH Jr, et al. Among authors: crawford j. Crit Rev Oncol Hematol. 2018 Sep;129:79-90. doi: 10.1016/j.critrevonc.2018.06.010. Epub 2018 Jun 19. Crit Rev Oncol Hematol. 2018. PMID: 30097240 Free article. Review.

5

What are the criteria for response to cachexia treatment?

Crawford J. Crawford J. Ann Palliat Med. 2019 Jan;8(1):43-49. doi: 10.21037/apm.2018.12.08. Ann Palliat Med. 2019. PMID: 30685983 Free article. Review.

6

Role of dietary carbohydrates on risk of lung cancer.

Tao J, Jatoi A, Crawford J, Lam WWT, Ho JC, Wang X, Pang H. Tao J, et al. Among authors: crawford j. Lung Cancer. 2021 May;155:87-93. doi: 10.1016/j.lungcan.2021.03.009. Epub 2021 Mar 17. Lung Cancer. 2021. PMID: 33756357

7

Associations between body mass index, weight loss and overall survival in patients with advanced lung cancer.

Oswalt C, Liu Y, Pang H, Le-Rademacher J, Wang X, Crawford J. Oswalt C, et al. Among authors: crawford j. J Cachexia Sarcopenia Muscle. 2022 Dec;13(6):2650-2660. doi: 10.1002/jcsm.13095. Epub 2022 Oct 20. J Cachexia Sarcopenia Muscle. 2022. PMID: 36268548 Free PMC article.

8

Recombinant human erythropoietin in cancer-related anemia. Review of clinical evidence.

Crawford J. Crawford J. Oncology (Williston Park). 2002 Sep;16(9 Suppl 10):41-53. Oncology (Williston Park). 2002. PMID: 12380954 Review.

9

Once-per-cycle pegfilgrastim (Neulasta) for the management of chemotherapy-induced neutropenia.

Crawford J. Crawford J. Semin Oncol. 2003 Aug;30(4 Suppl 13):24-30. doi: 10.1016/s0093-7754(03)00314-2. Semin Oncol. 2003. PMID: 14508717 Review.

10

The importance of chemotherapy dose intensity in lung cancer.

Crawford J. Crawford J. Semin Oncol. 2004 Dec;31(6 Suppl 15):25-31. doi: 10.1053/j.seminoncol.2004.11.025. Semin Oncol. 2004. PMID: 15726536 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,622 results

Search Page